ART outcomes | Worries reported at assessment for ART eligibility | |||||||
---|---|---|---|---|---|---|---|---|
No worry | One worry or more | Specific worries | ||||||
HIV status disclosure | Nutrition | Condoms use | Use of other medication | ART Adherence | ART side effects | |||
n=104 | n=195 | n=54 | n=38 | n=23 | n=26 | n=19 | n=19 | |
Total with CD4 counts after ART eligibility | 63 | 134 | 32 | 22 | 14 | 18 | 15 | 11 |
Mean CD4 counts increase (per year) (95% CI) | 162 | 199 | 112 | 127 | 97 | 363 | 189 | 156 |
(112-211) | (129-270) | (80-145) | (87-167) | (42-151) | (-19-746) | (56-322) | (-31-343) | |
Median CD4 increase | 92 | 114 | 73 | 112 | 74 | 122 | 115 | 168 |
(IQR) | (47-212) | (41-213) | (41-183) | (46-215) | (40-106) | (59-210) | (33-232) | (73-237) |
Total with viral loads | 54 | 126 | 33 | 24 | 14 | 16 | 15 | 12 |
CD4 count > 100 after ART start | 42 (78%) | 95 (75%) | 23 (70%) | 16 (67%) | 10 (71%) | 10 (63%) | 15 (100%) | 12 (100%) |
Annual decrease in median log VL (IQR) | 0.01 | −0.10* | −0.24* | 0.04* | 0.18 | 0.17 | −0.14 | 0.05 |
(-0.10-0.12) | (-0.19 - -0.02) | (-0.41 - -0.07) | (-0.12 - -0.21) | (0.01-0.35) | (0.12 - 0.33) | (-0.49 - 0.20) | (-0.02 - 0.30) | |
Number who started ART | 104 | 195 | 51 | 38 | 23 | 24 | 19 | 19 |
Substituted / switched ART | 29 (28%) | 53 (27%) | 16 (31%) | 7 (18%) | 6 (26%) | 8 (33%) | 3 (16%) | 7 (37%) |
Died | 19 (18%) | 13 (7%) | 5 (10%) | 4 (11%) | 1 (4%) | 1 (4%) | 0 (0) | 1 (5%) |